Target intelligence / Profile preview

BORCS8-MEF2B readthrough (BORCS8-MEF2B)

Target
BORCS8-MEF2B
Molecular classification
Other (readthrough transcript, with some protein-coding potential), transcription factor (for the MEF2B-derived protein isoform)
01

Overview

BORCS8-MEF2B readthrough is a hybrid transcript formed from transcriptional continuity between the BORCS8 and MEF2B gene loci. While most of its transcripts are predicted to be non-coding due to nonsense-mediated decay, some can translate into a MEF2B isoform, which can function as a transcription factor involved in muscle gene regulation and possibly nervous system development. Clinical associations are limited, though MEF2B alterations (not explicitly readthrough variants) have been linked to neurodegeneration and certain lymphomas. The readthrough gene itself is not commonly recognized as a druggable therapeutic target or receptor[1][2][3][7][4].

Other names
MEF2BNB-MEF2BGC19M019146GC19M019184GC19M092436GC19M096538GC19M100638GC19M104651GC19M108422
02

Biological functions

Transcription regulation (via MEF2B isoform)possible involvement in nervous system development and muscle gene activation
03

Disease associations

Limited—associated loci mention neurodegeneration (specifically infantile-onset neurodegeneration with optic atrophy and brain abnormalities)alterations in MEF2B itself are linked to diffuse large B-cell lymphoma

Beyond the preview

Go deeper on BORCS8-MEF2B readthrough (BORCS8-MEF2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BORCS8-MEF2B readthrough (BORCS8-MEF2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call